[Clinical effectiveness of Duracef in children with ENT inflammation].
106 children aged 4 to 14 years received duracef for different acute and chronic (exacerbation) ENT inflammation. The drug proved highly effective in acute diseases of the parynx, paranasal sinuses and ear. In exacerbations of chronic inflammatory diseases it was insufficiently effective. In acute inflammation use of duracef is beneficial as it is effective, inexpensive, low toxic, convenient in administration, is well tolerated, friendly to the intestine.
M R
MR
Bogomil'skiĭ
V R
VR
Chistiakova
D000208:Acute Disease; D000293:Adolescent; D002434:Cefadroxil / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy*; D010033:Otitis Media / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy*; D016896:Treatment Outcome
D002511:Cephalosporins; D002434:Cefadroxil